Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience

About

A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Articles from Mary Thompson:

Start-Ups

Sequel Med Tech Unveils Next-Gen, DEKA-Developed Insulin Delivery System

Sequel Med Tech, in collaboration with DEKA Research & Development, is preparing to launch the twiist automated insulin delivery system, a novel device that employs a “fundamentally different” mechanism of insulin delivery and is the first FDA-cleared AID to utilize Tidepool’s Loop algorithm. Although diabetes is the company’s first target, it has larger plans in the drug-delivery space.

Read Article